Why MUSC is building a new cancer hospital
Cancer is the second leading cause of death in South Carolina, accounting for approximately 11,000 deaths and 35,000 new cases each year. The state is projected to see a dramatic rise in cancer incidence, with new cases expected to increase by nearly 40% between 2023 and 2033. South Carolina also experiences higher-than-average rates of several cancers, including non-Hodgkin lymphoma and cancers of the breast, cervix, kidney, lung, mouth, throat, and pancreas.
As the population grows and ages, the demand for cancer prevention, treatment, and research continues to increase. The new hospital will allow MUSC to:
- Expand access to high‑quality cancer care.
- Recruit and retain top oncology clinicians and researchers.
- Increase capacity for advanced treatments and clinical trials.
- Provide a seamless, patient-centered “one-stop shop” experience.
- Strengthen statewide cancer care through the Hollings Cancer Network and other partnerships.
Statewide Impact
Patients and their families will be able to access leading-edge cancer care close to home, eliminating the need for out-of-state travel for advanced treatment. The new hospital will also bring significant benefits to South Carolina by helping MUSC recruit top physicians and scientists, supporting the growth of high-value jobs in the life sciences sector, and strengthening care for rural and underserved communities. In addition, it will advance Hollings' progress toward achieving National Cancer Institute (NCI) Comprehensive Cancer Center designation.
From a public health standpoint, the hospital will expand access to cancer screenings, prevention programs, and clinical trials, helping improve outcomes for communities across the state.